Impaired glucose tolerance in patients with amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 11, Issue 1-2, 2010, Pages 166-171

  Pradat, Pierre Francois ^a   Bruneteau, Gaelle ^a   Gordon, Paul H ^a   Dupuis, Luc ^b,c   Bonnefont Rousselot, Dominique ^a,d   Simon, Dominique ^a,b   Salachas, Francois ^a   Corcia, Philippe ^e   Frochot, Vincent ^a   Lacorte, Jean Marc ^a   Jardel, Claude ^a   Coussieu, Christiane ^a   Le Forestier, Nadine ^a   Lacomblez, Lucette ^a,b   Loeffler, Jean Philippe ^b,c   Meininger, Vincent ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CHU BRETONNEAU   (France)

Author keywords

Amyotrophic lateral sclerosis; Diabetes mellitus; Fatty acids; Glucose intolerance

Indexed keywords

ADIPONECTIN; FATTY ACID; GLUCOSE; INTERLEUKIN 6; LACTIC ACID; LEPTIN; PYRUVIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 77649312506     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960902822960     Document Type: Article

References (26)

1. Dupuis L, Corcia P, Fergani A, Gonzalez de Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidaemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004-9.
2. Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101:11159-64.
3. Fergani A, Oudart H, Gonzalez de Aguilar JL, Fricker B, Rene F, Hocquette JF, et al. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res. 2007;48:1571-80.
4. Gonzalez de Aguilar JL, Dupuis L, Oudart H, Loeffler JP. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn superoxide dismutase mice. Biomed Pharmacother. 2005;59:190-6.
5. Gonzalez de Aguilar JL, Echaniz-Laguna A, Fergani A, Rene F, Meininger V, Loeffler JP, et al. Amyotrophic lateral sclerosis: all roads lead to Rome. J Neurochem. 2007;101:1153-60.
6. Perurena OH, Festoff BW. Reduction in insulin receptors in amyotrophic lateral sclerosis correlates with reduced insulin sensitivity. Neurology. 1987;37:1375-9.
7. Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV. Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci. 1984;63:317-24.
8. Harno K, Rissanen A, Palo J. Glucose tolerance in amyotrophic lateral sclerosis. Acta Neurol Scand. 1984;70:451-5.
9. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
10. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRSR: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13-21.
11. Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L. Epidemiological features of glycated haemoglobin A1cdistribution in a healthy population. The Telecom Study. Diabetologia. 1989;32:864-9.
12. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-97.
13. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14:222-31.
14. Collis WJ, Engel WK. Glucose metabolism in five neuromuscular disorders. Neurology. 1968;18:915-25.
15. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med. 1998;49:235-61.
16. Stuart CA, Shangraw RE, Prince MJ, Peters EJ, Wolfe RR. Bed-rest-induced insulin resistance occurs primarily in muscle. Metabolism. 1988;37:802-6.
17. Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes. 2000;49:975-80.
18. Lindahl B, Weinehall L, Asplund K, Hallmans G. Screening for impaired glucose tolerance. Results from a populationbased study in 21,057 individuals. Diabetes Care. 1999; 22:1988-92.
19. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab. 2000;11:351-6.
20. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328-34.
21. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Shulman GI, et al. Impaired insulin sensitivity among non-diabetic patients with a recent TIA or ischaemic stroke. Neurology. 2003;60:1447-51.
22. Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med. 2004;82:510-29.
23. Sabayan B, Foroughinia F, Mowla A, Borhanihaghighi A. Role of insulin metabolism disturbances in the development of Alzheimer's disease: mini review. Am J Alzheimers Dis Other Demen. 2008;23:192-9.
24. Lalic NM,Maric J, SvetelM, Jotic A, Stefanova E, Lalic K, et al. Glucose homeostasis in Huntington's disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Arch Neurol. 2008;65:476-80.
25. Ronnemaa E, Zethelius B, Sundelof J, Sundstrom J, Degerman- Gunnarsson M, Berne C, et al. Impaired insulin secretion increases the risk of Alzheimer's disease. Neurology. 2008;71:1065-71.
26. Sandyk R. The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci. 1993;69:125-30.